Oasmia Pharmaceutical AB Price History
If you're considering investing in Oasmia Pink Sheet, it is important to understand the factors that can impact its price. We have found zero technical indicators for Oasmia Pharmaceutical, which you can use to evaluate the volatility of the company.
Oasmia Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Oasmia |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
OASMY |
Based on monthly moving average Oasmia Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oasmia Pharmaceutical by adding Oasmia Pharmaceutical to a well-diversified portfolio.
Oasmia Pharmaceutical Pink Sheet Price History Chart
There are several ways to analyze Oasmia Stock price data. The simplest method is using a basic Oasmia candlestick price chart, which shows Oasmia Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
No Historical data is available at this time
PX | 0.94 | ||||
PSEI | 0.45 | ||||
MXX | 0.02 | ||||
MERV | 0.00 | ||||
CFMDIVO | 0.12 | ||||
BETNG | 0.28 | ||||
ATG | 0.35 | ||||
XELKT | 0.49 | ||||
HNX 30 | 0.56 | ||||
TWII | 0.70 | ||||
AXDI | 0.85 | ||||
APACXJ | 0.89 | ||||
SET | 0.91 | ||||
IDX 30 | 0.97 | ||||
ASCX | 1.62 | ||||
PSI 20 | 1.64 | ||||
NYA | 1.65 | ||||
SLI | 1.70 | ||||
Tel Aviv | 1.83 | ||||
BELS | 1.99 | ||||
ISEQ 20 | 2.22 | ||||
IMAT | 2.24 | ||||
ATX | 2.35 | ||||
IBEX 35 | 2.55 | ||||
CROBEX | 2.61 | ||||
Budapest | 2.77 | ||||
OSEFX | 2.92 | ||||
GDAXI | 3.54 | ||||
WIG 30 | 3.77 | ||||
KLTE | 4.36 |
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Valuation Check real value of public entities based on technical and fundamental data |